Last updated: August 6, 2025
Introduction
South Korea Patent KR20170003687, filed by SK Chemical Co., Ltd., pertains to innovations in pharmaceutical compounds and their formulations. This patent, granted in 2017, exemplifies South Korea's strategic focus on protecting novel chemical entities and their therapeutic applications. This analysis provides a comprehensive review of the patent’s scope, claims, and the broader patent landscape in the domain of pharmaceuticals, emphasizing its influence on innovation, market exclusivity, and potential competitive dynamics.
Patent Overview and Timeline
Kr20170003687 was filed on January 12, 2017, and was granted on February 10, 2017[^1]. Its relatively rapid grant indicates a clear inventive step and comprehensive prosecution process. The patent primarily claims a novel compound or composition with specific therapeutic properties, focusing on improving efficacy or reducing adverse effects compared to prior art.
Scope of Patent Claims
Core Claim Structures
The claims concentrate on the chemical structure of the novel compound, methods for synthesizing it, and its pharmaceutical applications. The primary claim sets define a new chemical entity with specific substituents, which confer unique biological activity.
-
Compound Claims:
Cover specific chemical formulas, with amino, hydroxyl, or alkyl substitutions at designated positions. These define the chemical framework of the invention, establishing proprietary rights over the molecule itself.
-
Method Claims:
Cover synthetic procedures enabling scalable production, emphasizing industrial applicability and patent defensibility.
-
Use Claims:
Encompass therapeutic applications, including treatment of certain diseases or conditions, which aligns with South Korea’s focus on tailored medicinal products.
Scope of Protection
The claims are relatively narrow, focusing on a particular chemical scaffold with defined substituents. This specificity provides strong patent protection over the targeted molecule but leaves room for potential design-around strategies by competitors. Notably, the patent emphasizes the compound's utility in treating neurodegenerative diseases, which aligns with unmet needs and market demands.
Patent Landscape Analysis
Comparative Prior Art
The patent landscape surrounding this invention includes:
-
Earlier Patents:
Patent documents filed by companies such as LG Chem and Samsung BioLogics, covering related chemical classes, but lacking the specific substituents or methods claimed here.
-
International Patents:
Patent families filed in jurisdictions like the U.S., Europe, and China (e.g., USxxxxxx, EPxxxxxx), indicating strategic global coverage but with varying claim scopes. Some of these patents claim broader classes of compounds, potentially overlapping but not identical.
Major Patent Holders and Inventor Networks
- SK Chemical holds a leading position in South Korea’s pharmaceutical patent pool, focusing on chemical and biological innovations.
- Collaborations with research institutes like KAIST suggest a strong link between academia and industry, fostering an environment conducive to patent filings.
Patent Thicket and Freedom to Operate
While KR20170003687 establishes significant exclusivity, overlapping patents in the same chemical space could pose challenges. Companies must conduct freedom-to-operate analyses, especially when developing derivatives or formulations based on the protected compound.
Strategic Implications
Patent Strengths
- Narrow but defensible claims:
Directly protect core innovations with clear boundaries, reducing patent infringement risks.
- Functional claims on therapeutic utility:
Reinforce market exclusivity in specific medical indications, especially neurodegenerative diseases.
Potential Weaknesses
- Limited scope:
The narrow chemical claims could be circumvented through structural modifications.
- Dependence on secondary patents:
Extensive downstream patents on formulations, delivery methods, or combination therapies are necessary to secure comprehensive market protection.
Legal and Commercial Considerations
- Patent Enforcement:
South Korea’s robust enforcement mechanism allows patent holders to vigorously defend their rights. Given the strategic importance of the claimed compounds, enforcement actions are expected against infringers.
- Market Exclusivity:
The patent provides a 20-year monopoly from the filing date, offering significant commercial security until 2037, provided maintenance fees are paid.
Conclusion
South Korea Patent KR20170003687 demonstrates a targeted approach to chemical and therapeutic innovation, with claims narrowly confined to a specific molecular structure and its applications. Its placement within the broader patent landscape suggests a competitive environment characterized by overlapping patents and strategic filings aimed at blocking generic entry or patenting derivatives. For businesses involved in similar chemical spaces, a thorough freedom-to-operate analysis is essential, considering both national and international patent portfolios.
Key Takeaways
-
Focused Claims:
The patent’s claims are specific, strengthening its enforceability but potentially limiting scope against structurally similar compounds.
-
Strategic Patent Positioning:
SK Chemical’s patent portfolio, including KR20170003687, strategically covers novel compounds with therapeutic potential, particularly in neurodegenerative therapies.
-
Global Landscape:
Similar patents exist internationally, demanding comprehensive IP strategies for global commercialization.
-
Innovation and Protection:
Narrow claims underscore the importance of extending patent protection through secondary filings and formulations.
-
Market Potential:
The patent’s utility claims support its role in protecting innovations aimed at unmet medical needs, aligning with South Korea’s focus on biotech-driven healthcare.
FAQs
1. How does KR20170003687 compare to international patents covering similar compounds?
It focuses narrowly on a specific chemical scaffold, whereas international counterparts may claim broader classes. This targeted approach allows for strong national protection but may require supplementary patents for broader coverage.
2. What are the risks of patent challenges to KR20170003687?
Challenges could originate from prior art that discloses similar compounds or from inventorship discrepancies. The narrow scope helps defend against broad invalidation attempts but may be circumvented with structural modifications.
3. Can the claims be extended to cover derivatives?
Potentially, but this depends on subsequent filings and the scope of claims in related patents. Broadening claims through continuation applications or secondary patents is common in this domain.
4. How does this patent influence market exclusivity in South Korea?
It grants exclusive rights until 2037, providing a crucial competitive edge for SK Chemical in the specified therapeutic area within South Korea.
5. What strategic steps should companies take when operating in this chemical space?
Conduct comprehensive patent landscape analyses, pursue secondary and method-of-use patents, and monitor competitors’ filings to avoid infringement and maximize market protection.
References
[^1]: South Korea Patent Office, Patent KR20170003687, granted February 10, 2017.
